|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou K, Wang L, Cheng R, Liu X, Mao S and
Yan Y: Elemene increases autophagic apoptosis and drug sensitivity
in human cisplatin (DDP)-resistant lung cancer cell line
SPC-A-1/DDP By inducing beclin-1 expression. Oncol Res. 2017.(Epub
ahead of print). View Article : Google Scholar
|
|
3
|
Hu Y, Zhu QN, Deng JL, Li ZX, Wang G and
Zhu YS: Emerging role of long non-coding RNAs in cisplatin
resistance. OncoTargets Ther. 11:3185–3194. 2018. View Article : Google Scholar
|
|
4
|
Zhang S, Ma H, Zhang D, Xie S, Wang W, Li
Q, Lin Z and Wang Y: LncRNA KCNQ1OT1 regulates proliferation and
cisplatin resistance in tongue cancer via miR-211-5p mediated
Ezrin/Fak/Src signaling. Cell Death Dis. 9:7422018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu F, Li J, Du X, Zhang W, Lei P and Zhang
Q: Long noncoding RNA AB019562 promotes cell proliferation and
metastasis in human hepatocellular carcinoma. Mol Med Rep.
16:69–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu B, Zhang H, Wang Z, Zhang F, Wei H and
Li L: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance
in non-small-cell lung cancer cell line by targeting SOX4. Cancer
Biol Ther. 18:974–983. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma LY, Xie XW, Ma L, Pang JL, Xiong XM,
Zheng HD, Shen XL, Wen ZG and Wang HY: Downregulated long
non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small
cell lung cancer cells via activation of p53- p66shc pathway. Eur
Rev Med Pharmacol Sci. 21:2626–2634. 2017.PubMed/NCBI
|
|
8
|
Wang J, Luo Z, Yao T, Li W and Pu J:
LINC00707 promotes hepatocellular carcinoma progression through
activating ERK/JNK/AKT pathway signaling pathway. J Cell Physiol.
234:6908–6916. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie M, Ma T, Xue J, Ma H, Sun M, Zhang Z,
Liu M, Liu Y, Ju S, Wang Z and De W: The long intergenic
non-protein coding RNA 707 promotes proliferation and metastasis of
gastric cancer by interacting with mRNA stabilizing protein HuR.
Cancer Lett. 443:67–79. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma T, Ma H, Zou Z, He X, Liu Y, Shuai Y,
Xie M and Zhang Z: The long intergenic noncoding RNA 00707 promotes
lung adenocarcinoma cell proliferation and migration by regulating
Cdc42. Cell Physiol Biochem. 45:1566–1580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan Y, Haiying G, Zhuo L, Ying L and Xin
H: Long non-coding RNA LINC00339 facilitates the tumorigenesis of
non-small cell lung cancer by sponging miR-145 through targeting
FOXM1. Biomed Pharmacother. 105:707–713. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Xing Y and Rong L: miR-181
regulates cisplatin-resistant non-small cell lung cancer via
downregulation of autophagy through the PTEN/PI3K/AKT pathway.
Oncol Rep. 39:1631–1639. 2018.PubMed/NCBI
|
|
14
|
Liu K, Chen H, You Q, Ye Q, Wang F, Wang
S, Zhang S, Yu K, Li W and Gu M: miR145 inhibits human
nonsmall-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
Int J Oncol. 53:257–265. 2018.PubMed/NCBI
|
|
15
|
Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang
W, Shen H, Huang S and Wang J: miR-145 sensitizes gallbladder
cancer to cisplatin by regulating multidrug resistance associated
protein 1. Tumour Biol. 37:10553–10562. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thatcher N, Hirsch FR, Luft AV, Szczesna
A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy
G, et al: Necitumumab plus gemcitabine and cisplatin versus
gemcitabine and cisplatin alone as first-line therapy in patients
with stage IV squamous non-small-cell lung cancer (SQUIRE): An
open-label, randomised, controlled phase 3 trial. Lancet Oncol.
16:763–774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Chen D, Ma H and Li Y: LncRNA MEG3
enhances cisplatin sensitivity in non-small cell lung cancer by
regulating miR-21-5p/SOX7 axis. Onco Targets Ther. 10:5137–5149.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen QN, Wei CC, Wang ZX and Sun M: Long
non-coding RNAs in anti-cancer drug resistance. Oncotarget.
8:1925–1936. 2017.PubMed/NCBI
|
|
20
|
Tekchandani P, Kurmi BD and Paliwal SR:
Nanomedicine to deal with cancer cell biology in multi-drug
resistance. Mini Rev Med Chem. 17:1793–1810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia B, Wang Z, Sun X, Chen J, Zhao J and
Qiu X: Long noncoding RNA LINC00707 sponges miR-370-3p to promote
osteogenesis of human bone marrow-derived mesenchymal stem cells
through upregulating WNT2B. Stem Cell Res Ther. 10:672019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tu J, Zhao Z, Xu M, Chen M, Weng Q, Wang J
and Ji J: LINC00707 contributes to hepatocellular carcinoma
progression via sponging miR-206 to increase CDK14. J Cell Physiol.
234:10615–10624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sheng N, Tan G, You W, Chen H, Gong J,
Chen D, Zhang H and Wang Z: MiR-145 inhibits human colorectal
cancer cell migration and invasion via PAK4-dependent pathway.
Cancer Med. 6:1331–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding Y, Zhang C, Zhang J, Zhang N, Li T,
Fang J, Zhang Y, Zuo F, Tao Z, Tang S, et al: miR-145 inhibits
proliferation and migration of breast cancer cells by directly or
indirectly regulating TGF-β1 expression. Int J Oncol. 50:1701–1710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li JC and Zheng JQ: Effect of microRNA-145
on proliferation and apoptosis of human non-small cell lung cancer
A549 cells by regulating mTOR signaling pathway. J Cell Biochem.
2017.(Epub ahead of print). View Article : Google Scholar
|
|
26
|
Zhou X, Yue Y, Wang R, Gong B and Duan Z:
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer
stem cells. Int J Oncol. 50:853–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
